Conference/Tweets/Presentations/News, page-9

BUD mkt cap is at $134m with annualised revenue so far known of $1.67m, so that gives 80.3x Mcap/Sales. Ok you take the $23m out (provided its still intact, probably not with all the travels and shows and maybe more share based expenses) I give you, its 66.47x. No longer triple digits and now priced BUD close to Yojee's $130m (which is way overvalued IMO at 293x revenue).

If you had sold some of your shares when I cautioned at 20c , you could now easily buy them back at 12c.
This is what happens when people wait and see, and failing to see the signs (despite my numerous posts).
It has now fallen 70% from its all time high , so the short term downside I think is limited, unless large players decide to exit. But the pain is not over in the longer term if DM can't walk his talk.

Signing a sizeable contract sales e.g securing a global Nestle deal is greater validation than appointing more distributors or extending their geographical coverage. All that gives the impression that the larger picture is ahead of us, perhaps, perhaps not. It all depends on whether its products can achieve market traction in a crowded market.

Those of you who missed out my EDE example can search up my prior posts on it.